Awards/COOPERATIVE AGREEMENT (B)

$296,551,353

Department of Health and Human Services·Centers for Disease Control and Prevention

ACTION DATE—·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000548_075

Award description

2019 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASE (ELC)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds state epidemiology and laboratory capacity to detect, prevent, and control emerging infectious diseases.

Sub-sectors

infectious-diseasepublic-health-infrastructureepidemiology

Why this matters

Strengthens U.S. disease surveillance and response infrastructure critical for pandemic preparedness and biosecurity.

Supply-chain signal

Increases demand for diagnostic equipment, laboratory reagents, and bioinformatics systems from suppliers.

U.S.–China competition angle

Enhances U.S. domestic disease detection capabilities independent of foreign reliance during health emergencies.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-13. Cost: $0.001293.

Period of performance

Start

2019-08-01

End

2027-07-31

Status

activein 443 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000548_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.